2 unknown, 1 recruiting. 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow Ferric Derisomaltose Injection: new trials by email Literature Review of Ferric Derisomaltose Injection trials Research Report on Ferric Derisomaltose Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting Conditions Ferric Derisomaltose Injection, Ferric Derisomaltose Injection [MonoFer®] - Iron Deficiency Anemia | Phase 1 | Recruiting | Sichuan Huiyu Pharmaceutical Co., Ltd | 88 | 2026-07-23 | 2026-10-13 |
| High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia Ferric Derisomaltose Injection, Darbepoetin Alfa Injection - Anemia | Phase 3 | Unknown | Hallym University Medical Center | 312 | 2023-03-01 | 2023-03-15 |
| Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Ferric Derisomaltose Injection, Normal saline - Gynecologic Cancer, Anemia, Iron Deficiency | Phase 3 | Unknown | Alberta Health Services, Calgary | 82 | 2022-09-30 | 2022-07-20 |
Anemia, Iron-Deficiency (2) · Anemia (1)
Alberta Health Services, Calgary (1) · Hallym University Medical Center (1) · Sichuan Huiyu Pharmaceutical Co., Ltd (1)
China (1) · South Korea (1)